News

­­­­­­­­­­­­­­­­­­­­Shriners Children’s Boston Fellowship Program Promotes Promising Advances in Burn Care

Feb 16, 2024 https://www.shrinerschildrens.org/en/News-and-Media/News/2024/02/Research-Promotes-Promising-Advances-in-Burn-Care

Irina Filz von Reiterdank, M.D.'s work involving the genetic modification of transplant organs holds tremendous promise in the treatment of severe burn injuries.

News

Shriners Children’s Doctor Colleen Ryan Breaks New Ground in Burn Care

Oct 04, 2024 https://www.shrinerschildrens.org/en/News-and-Media/News/2024/10/Research-Spotlight-Burn-Care

The Boston surgeon and researcher has studied the field for more than 35 years.

News

Shriners Children's St. Louis Advances Groundbreaking Research in Gene Therapy

Oct 17, 2024 https://www.shrinerschildrens.org/en/News-and-Media/News/2024/10/Groundbreaking-Research-in-Gene-Therapy

Using gene therapy, a pair of doctors from Shriners Children’s St. Louis have discovered a revolutionary new way to battle childhood obesity by converting harmful fatty acids into beneficial ones.

News

Shriners Children’s Therapists Refine Innovative Infant Mobility Toy

Oct 18, 2024 https://www.shrinerschildrens.org/en/News-and-Media/News/2024/10/Research-Spotlight-Infant-Mobility

The Salt Lake City team shares the Baby Bug Learning Toy for children with mobility impairments.

News

Spina Bifida Treatment Approved by FDA for Human Clinical Trials

Oct 08, 2020 https://www.shrinerschildrens.org/en/News-and-Media/News/2020/10/Spina-bifida-treatment-approved-by-FDA-for-human-clinical-trials

Shriners Hospitals for Children — Northern California’s surgeon in chief, Diana Farmer, M.D., and principal investigator for the Institute for Pediatric Regenerative Medicine, Aijun Wang, Ph.D., have received approval for a human clinical trial from the U.S. Food and Drug Administration (FDA) to tes...

News

Shriners Children’s St. Louis Leads Way in Rheumatoid Arthritis Treatment

Jan 31, 2022 https://www.shrinerschildrens.org/en/News-and-Media/News/2022/01/Rheumatoid-Arthritis-Research

Study shows modified cells automatically release biologic drug in response to inflammation. Shriners Children's Farshid Guilak, Ph.D. leads this revolutionary research.

News

25 Years of Pioneering Care at Shriners Children's Neil Reitman Pediatric Burn Institute

Dec 07, 2022 https://www.shrinerschildrens.org/en/News-and-Media/News/2022/11/Neil-Reitman-Pediatric-Burn-Institute

25 years of pioneering advancements in burn care makes Shriners Children’s Neil Reitman Pediatric Burn Institute a global leader in treatment and care.

News

Canada Research Continuity Emergency Fund (CRCEF) Strategy for Equity, Diversity and Inclusion

Sep 09, 2020 https://www.shrinerschildrens.org/en/News-and-Media/News/2020/09/Canada-Research-Continuity-Emergency-Fund-CRCEF-strategy-for-equity-diversity-and-inclusion

On May 15, 2020, the government of Canada announced the Canada Research Continuity Emergency Fund (CRCEF) as part of its COVID-19 Economic Response Plan.

News

Shriners Children’s Spokane Cerebral Palsy Study Assesses Spasticity Treatments

Mar 23, 2022 https://www.shrinerschildrens.org/en/News-and-Media/News/2022/03/Cerebral-Palsy-Study

Shriners Children’s Spokane, along with Shriners Children’s Salt Lake City and Gillette Children’s Specialty Healthcare, revealed the results of an in-depth cerebral palsy research study.

News

Year in Review: Shriners Children's Celebrates Achievements from 2022

Dec 20, 2022 https://www.shrinerschildrens.org/en/News-and-Media/News/2022/12/Year-in-Review

A look back at some of the biggest stories of the year.